H5Q (p.His5Gln) variant of CASQ2 (Calsequestrin-2)

H5Q (p.His5Gln) in CASQ2 (Calsequestrin-2) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.19 / 1. The record also includes population frequency data and structural context.

H5Q (p.His5Gln) variant details